Taglich Brothers Reiterates Buy Rating on OxySure Systems, Inc. (OXYS); Target Price $2.10 Per Share
OxySure Systems, a medical technology company that has pioneered an FDA-approved solution to produce medically pure oxygen from dry, inert…
OxySure Systems, a medical technology company that has pioneered an FDA-approved solution to produce medically pure oxygen from dry, inert…
Home prices are going up, but don’t call it a bubble just yet. Data from Thursday showed that home prices…
The Wall Street Transcript, a long-standing publication and Web site that issues industry reports featuring interviews with top company executives,…
Poly Shield Technologies markets environmental, pollution emissions, energy saving, corrosion, and durability solutions to a number of industries. Its flagship…
AMSC is sitting just above a support level at $2.35 and forming an inverted head and shoulders pattern. The support…
Monarchy Resources is currently the subject of an email spam campaign. Investors should be wary of these emails, as they…
Identive Group, which is cutting across the spectrum of identity management markets with their RFID-centric, Secure ID platforms, broke the…
Today, interactive media, mobile marketing, and mobile advertising technology and services leader Augme Technologies announced the change of its name…
For years, the worldwide pharmaceutical stage has been dominated by the giant pharmaceutical companies of North America and Europe. With…
Premier Biomedical is a research-based company that intends to discover and develop medical treatments for a variety of disease such…